Therapy of relapsed and relapsed-refractory Multiple Myeloma

被引：0
|
作者：
Driessen, C. [1 ]
机构：
[1] Kantonsspital St Gallen, Onkol Hamatol, St Gallen, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
694
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [11] Bortezomib in patients with relapsed-refractory multiple myeloma (MM). Clinical observations.
    Kyrtsonis, MC
    Sachanas, S
    Vassilakopoulos, TP
    Kafassi, N
    Tzenou, T
    Papadogiannis, A
    Kalpadakis, C
    Antoniadis, AG
    Dimopoulou, MN
    Angelopoulou, MK
    Siakantaris, MP
    Dimitriadou, EM
    Kokoris, SI
    Plata, E
    Tsaftaridis, P
    Panayiotidis, P
    Pangalis, GA
    BLOOD, 2005, 106 (11) : 382B - 382B
  • [12] Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data
    Offidani, Massimo
    Corvatta, Laura
    Caraffa, Patrizia
    Leoni, Pietro
    Pautasso, Chiara
    Larocca, Alessandra
    Palumbo, Antonio
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (05) : 499 - 510
  • [13] VENETOCLAX AS TARGETED THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Kumar, S.
    Kaufman, J. L.
    Mikhael, J.
    Gasparetto, C.
    Vij, R.
    Pegourie, B.
    Benboubker, L.
    Facon, T.
    Moreau, P.
    Amiot, M.
    Alzate, S.
    Dunbar, M.
    Xu, T.
    Agarwal, S.
    Leverson, J.
    Ross, J.
    Maciag, P.
    Verdugo, M.
    Touzeau, C.
    HAEMATOLOGICA, 2017, 102 : 268 - 269
  • [14] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, M.
    Truger, M.
    Bittrich, M.
    Zhou, X.
    Noderer, J.
    Riedhammer, C.
    Xiao, X.
    Gawlas, S.
    Philipp, W.
    Eisele, F.
    Haferlach, C.
    Mersi, J.
    Waldschmidt, J.
    Einsele, H.
    Rasche, L.
    Kortuem, K. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 58 - 58
  • [15] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, Maximilian J.
    Truger, Marietta
    Bittrich, Max
    Zhou, Xiang
    Noderer, Julia
    Riedhammer, Christine
    Xiao, Xianghui
    Gawlas, Sophia
    Weis, Philipp
    Eisele, Florian
    Haferlach, Claudia
    Mersi, Julia
    Waldschmidt, Johannes
    Einsele, Hermann
    Rasche, Leo
    Kortuem, K. Martin
    HAEMATOLOGICA, 2024, 109 (03) : 979 - 981
  • [16] LENALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Okada, K.
    Okamoto, Y.
    Tsukamoto, T.
    Sugiura, H.
    Matsui, H.
    Ueda, T.
    Jo, T.
    Onishi, T.
    Kunitomi, A.
    Ueda, Y.
    ANNALS OF ONCOLOGY, 2013, 24
  • [17] NK cell therapy in relapsed refractory multiple myeloma
    Roshandel, Elham
    Ghaffari-Nazari, Haniyeh
    Mohammadian, Mozhdeh
    Salimi, Maryam
    Abroun, Saeid
    Mirfakhraie, Reza
    Hajifathali, Abbas
    CLINICAL IMMUNOLOGY, 2023, 246
  • [18] Bendamustine therapy for advanced relapsed/refractory multiple myeloma
    Shkury, Eden
    Geva, Mika
    Avigdor, Abraham
    Nevo, Lee
    Magen, Hila
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S189 - S189
  • [19] Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma
    Kumar, S.
    Kaufman, J. L.
    Mikhael, J.
    Gasparetto, C.
    Vij, R.
    Pegourie, B.
    Benboubker, L.
    Facon, T.
    Moreau, P.
    Amiot, M.
    Alzate, S.
    Dunbar, M.
    Xu, T.
    Agarwal, S.
    Leverson, J.
    Ross, J.
    Maciag, P.
    Verdugo, M.
    Touzeau, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 100 - 101
  • [20] Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma
    Kumar, Shaji
    Kaufman, Jonathan L.
    Mikhael, Joseph
    Gasparetto, Cristina
    Vij, Ravi
    Pegourie, Brigitte
    Benboubker, Lofti
    Facon, Thierry
    Moreau, Philippe
    Amiot, Martine
    Alzate, Stefanie
    Dunbar, Martin
    Xu, Tu
    Agarwal, Suresh
    Leverson, Joel
    Ross, Jeremy
    Maciag, Paulo
    Verdugo, Maria
    Touzeau, Cyrille
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E27 - E27
12345